Roger Haber is a Dermatology physician affiliated with University of Illinois Urbana-Champaign. OpenAlex indexes 69 publications with 737 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
808 S Wood St Ste 380
Chicago, IL 606127300
Telephone
312-413-7448Provider last certified this registry record 5 Mar 2025.
Clinical trials
- Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus
Sponsor: University of Balamand
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
- GENZYME CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
40.5%Azole Antifungal28%Ketoconazole100%Part D≥49 patientsLincosamide Antibacterial8.1%Clindamycin Phosphate100%Part D≥12 patients+ 1 more class in this area
Dermatology
22.5%Corticosteroid22.5%Triamcinolone Acetonide100%Part D≥49 patientsSensory organs
17.6%Corticosteroid17.6%Hydrocortisone59%Clobetasol Propionate41%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Wells syndrome: emerging triggers and treatments– an updated systematic review
Archives of Dermatological Research
2025 - Rosacea and Migraine: A Systematic Review and Meta‐Analysis Update
International Journal of Dermatology
2025 - Pigmentary demarcation lines: Three cases encapsulating a benign condition
Journal of Family Medicine and Primary Care
2025 - Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome
Journal of the American Academy of Dermatology
2025 - 59558 Janus Kinase and Tyrosine Kinase Inhibitors for Hidradenitis Suppurativa: a Meta-Analysis of Randomized Controlled Trials
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Issam Moussa, MD
University of Illinois Urbana-Champaign
Ali Alaraj, MD
University of Illinois Urbana-Champaign
Thasarat Vajaranant, MD
University of Illinois Urbana-Champaign
Janet Jokela, MD
University of Illinois Urbana-Champaign
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”